Influenza viruses
CEL-SCI Corporation Develops Immune-Based Treatment for Swine Flu and H1N1 Viruses
CEL-SCI Corporation has announced the development of an immune-based treatment for the swine flu and related H1N1 viruses, utilizing its proprietary L.E.A.P.S.(TM) vaccine technology. The company aims to leverage its expertise in developing protective and therapeutic vaccines to create a therapeutic treatment for individuals infected